Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38673 POSTS 0 COMMENTS
In patients co-infected with HIV and hepatitis C virus (HCV)

Risk of Diabetes Down With HCV SVR in HIV/HCV Coinfection

0
Sustained viral response linked to reduction in risk of diabetes, trend toward reduced risk of renal failure
For patients with type 1 diabetes

Ketone Monitoring Infrequent in Patients With Type 1 Diabetes

0
Thirty and 20 percent of participants, respectively, reported never and rarely checking ketones
For young patients with endometrial cancer

HT to Preserve Fertility Doesn’t Appreciably Affect Survival

0
Findings for young women with endometrial cancer

Society of Critical Care Medicine, Jan. 21-25

0
The Society of Critical Care Medicine's 46th Critical Care Congress The annual Society of Critical Medicine's Critical Care Congress was held from Jan....
Nearly two-thirds of boys and girls ages 2 to 19 in the United States drink at least one sugar-sweetened beverage daily

Most U.S. Children Consume at Least One Sugary Drink a Day

0
And calories consumed from sugary beverages on a given day increase with age for U.S. youth
Despite the dangers

28% of Adults, 9% of Teens Use Tobacco Products in U.S.

0
About 40 percent of tobacco users report use of multiple products
Anxiety and depression may increase the risk of death from certain cancers

Anxiety, Depression May Up Mortality Risk for Some Cancers

0
Higher death rates seen for colorectal, esophageal, pancreatic, and prostate cancers, leukemia
Treatment of subclinical hypothyroidism in pregnancy may not always be the best option

Study Questions Tx of Subclinical Hypothyroidism in Pregnancy

0
Increased risk of pregnancy related adverse outcomes calls for further study
Medical professionals give widely varying opinions about whether claimants for work disability benefits should get those benefits

Doctors’ Opinions Vary Widely on Approval of Disability Benefits

0
International study finds wide variance in how medical professionals determine benefit recipients
Bezlotoxumab (Zinplava) is effective in reducing the risk of recurrent Clostridium difficile infection

Bezlotoxumab Promising Against Recurrent Clostridium difficile

0
Medication cuts risk of recurrent C. difficile infections by 40 percent